Peter et al. (14) reported an interesting American cohort study that the incidence rate of PD in patients with IBD treated with anti-TNF was reduced by 78% compared with those without exposure, which supported the role of systemic inflammation in the pathogenesis of both IBD and PD. The gene discussed is TNF; the disease is Parkinson disease.